Growth Metrics

Biofrontera (BFRI) Capital Expenditures (2021 - 2025)

Biofrontera has reported Capital Expenditures over the past 5 years, most recently at -$1000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 97.5% year-over-year to -$1000.0; the TTM value through Dec 2025 reached $2000.0, down 80.0%, while the annual FY2025 figure was $2000.0, 80.0% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$1000.0 at Biofrontera, roughly flat from -$1000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $57000.0 in Q1 2024 and troughed at -$40000.0 in Q4 2024.
  • A 5-year average of $4200.0 and a median of $1000.0 in 2022 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: tumbled 1000.0% in 2023 and later soared 307.14% in 2024.
  • Year by year, Capital Expenditures stood at $9000.0 in 2021, then tumbled by 88.89% to $1000.0 in 2022, then tumbled by 1000.0% to -$9000.0 in 2023, then plummeted by 344.44% to -$40000.0 in 2024, then surged by 97.5% to -$1000.0 in 2025.
  • Business Quant data shows Capital Expenditures for BFRI at -$1000.0 in Q4 2025, -$1000.0 in Q3 2025, and $1000.0 in Q2 2025.